We examined the molecular characteristics of 13 phenotypically confirmed carbapenemasepositive Enterobacteriaceae clinical isolates, including the relationships between plasmidmediated quinolone-resistance genes (qnr), 69-N-aminoglycoside acetyltransferase-encoding genes [aac(69)] and AmpC-encoding genes (pAmpC). Twelve isolates were bla IMP-1 positive (92.3 %), while one was bla IMP-11 positive (7.7 %). We detected qnr, aac(69) and pAmpC genes designated bla ACT-1 -like in 76.9 %, 100 % and 53.8 %, respectively, of the 13 isolates. Plasmids were transferred successfully for three of the 13 metallo-b-lactamase (MBL)-producing isolates, and the sizes of plasmids extracted from these donors and transconjugants were deduced to be 65 kb or 70 kb. OmpC or OmpF protein expression was reduced in all Enterobacter cloacae, and one Klebsiella oxytoca lacked OmpK36. We demonstrate what appears to be the first evidence that, in Japan, Enterobacteriaceae producing MBLs carry various plasmid-mediated resistance genes, which may cause a further decrease in carbapenem susceptibility through reduction of the expression of outer-membrane proteins.
INTRODUCTION
In Enterobacteriaceae-related infections, resistance to carbapenems, which are used to treat multidrug-resistant bacterial infections, is an increasingly serious worldwide problem (Hawkey & Jones, 2009 ). Carbapenem resistance involves production of acquired carbapenemases [metallob-lactamases (MBLs) such as IMP, VIM and NDM-1, and OXA-or KPC-related non-metallo-carbapenemases], AmpC b-lactamase hyperexpression, reduced permeation of antimicrobials due to loss of outer-membrane proteins (OMPs), and overexpression of the efflux pump (Hawkey & Jones, 2009; Kumarasamy et al., 2010) . Carbapenemase genes are mainly contained in integrons with resistance genes against various antibiotics, including quinolone or aminoglycosides. To characterize the molecular mechanisms of carbapenem-resistant Enterobacteriaceae in Japan, we investigated molecular characteristics of such clinical isolates, including the relative contributions of impermeability and the efflux system. We also examined genetic relationships between plasmid-mediated quinolone resistance (PMQR) genes, 69-N-aminoglycoside acetyltransferase [AAC(69)]-encoding genes and plasmid-mediated AmpC-encoding (pAmpC) genes.
METHODS
Bacterial strains. We examined 13 phenotypically confirmed carbapenemase-positive isolates of 29 clinical isolates with imipenem (IPM) or meropenem (MEM) MICs ¢2 mg l 21 among 1704 Enterobacteriaceae clinical isolates collected at the University of Tokyo Hospital (Tokyo, Japan), a 1210-bed teaching hospital, between April 2007 and March 2009. These isolates comprised 10 Enterobacter cloacae, one Klebsiella oxytoca, one Citrobacter freundii and one Serratia marcescens, obtained from various biological samples (sputum, throat swab, urine, wound, bile and venous catheter).
Susceptibility testing. Carbapenemase production was screened by the modified Hodge test (CLSI, 2011) . MBL and extended-spectrum b-lactamase production was confirmed by the double-disc synergy test (Arakawa et al., 2000; CLSI, 2011) using mercaptoacetic acid and clavulanic acid, respectively, as b-lactamase inhibitors. Class C blactamase production was confirmed as described previously (Yagi et al., 2005) instructions. Both strands of purified PCR fragments were sequenced with an ABI PRISM 3100 DNA sequencer (Applied Biosystems) and a similarity search was conducted using the BLAST program (DDBJ).
Detection of carbapenemase genes, PMQR genes, AAC(6 §)encoding genes and pAmpC genes. The presence of carbapenemase genes (bla IMP , bla VIM and bla KPC ), PMQR genes [qnrA, qnrB, qnrS and aac(69)-Ib-cr], AAC(69)-encoding genes [aac(69)-Ib and -IIc] and pAmpC genes was determined using published primer sequences in the 13 phenotypically confirmed carbapenemase-positive isolates (Ode et al., 2009; Pérez-Pérez & Hanson, 2002) . The genetic diversity of isolates possessing MBL genes was analysed by repetitive element sequence-based PCR (Rep-PCR) (Shannon & French, 2004) . BioNumerics software (version 4.0, Applied Maths) was used to analyse the DNA patterns and determine their similarity.
Conjugation experiments, extraction of plasmids, structure analysis of gene cassettes and Southern hybridization experiments. Conjugation experiments were performed as described previously (Ode et al., 2009) . Whole plasmid DNA was extracted from donors and transconjugants by alkaline lysis miniprep. The content and order of the gene cassettes inserted between the 59conserved segment (CS) and 39-CS were determined as described previously (Ode et al., 2009) . Southern hybridization experiments were performed using the DIG-High Prime DNA Labelling and Detection Starter Kit I (Roche Diagnostics).
Analysis of outer-membrane proteins (OMPs). OMPs were isolated by the rapid procedure of Carlone et al. (1986) . Concentrations of OMPs were determined by BCA protein assay kit (Thermo Fisher Scientific). OMPs (20 mg) were resolved using 12.5 % (E. cloacae) or 10 % SDS-PAGE (K. oxytoca, C. freundii and S. marcescens) and stained with Coomassie blue. OMP profiles were compared to those of the relevant IPM-susceptible strains. The band intensities of the OMPs were analysed using Image J (NIH).
Effects of efflux pump inhibitor. Susceptibility testing of IPM and MEM was performed by microbroth dilution with and without the efflux pump inhibitor (EPI) L-phenylalanine-arginine-N-naphthylamide (Sigma-Aldrich) as described previously (Kumita et al., 2009) . In comparison to MICs with and without the EPI, a twofold or greater decrease in MICs for each antibiotic indicated a significant change. Effects of the EPI were determined in triplicate.
RESULTS AND DISCUSSION
In the present study, the IPM or MEM MICs were ¢2 mg l 21 for 29 isolates (1.7 %), and 13 isolates (0.8 %) were carbapenemase producers; this result was also phenotypically confirmed. Among these isolates, none produced extended-spectrum b-lactamases. Twelve (92.3 %) of the 13 carbapenemase-producing Enterobacteriaceae clinical isolates (10 E. cloacae, one K. oxytoca and one C. freundii) were bla IMP-1 positive. One (7.7 %) bla IMP-11 -positive S. marcescens isolate was also detected, similar to Takahashi et al. (2010) , but no bla KPC . Rep-PCR revealed four identical banding-patterns in the bla IMP-1 -positive E. cloacae, indicating the existence of four clonal genotypes (group I, E9 and E13; group II, E17; group III, E19, E20, E25, E26 and E29; and group IV, E22 and E23). MBLpositive Enterobacteriaceae isolates reportedly do not confer high-level resistance to IPM (Hirakata et al., 1998) . Since the IPM and MEM MICs found for three MBL-producing isolates were susceptible or intermediate with respect to interpretive criteria (MIC ¡2 mg l 21 ), our results also demonstrated the need to ascertain MBL status in Enterobacteriaceae isolates with such IPM MICs. Moreover, a previous study has shown that the carbapenem resistance rate of Enterobacteriaceae was approximately 1.2 %, and that the IMP-type MBL is the most commonly detected among MBL-producing Enterobacteriaceae in Japan (Nishio et al., 2004) . Although we tested only the carbapenemase genes bla IMP , bla VIM and bla KPC , our finding was also in agreement with that of this previous study. However, we did not investigate whether the other carbapenemase genes, including bla NDM-1 , were present in the 29 clinical isolates with MIC ¢2 mg l 21 for IPM or MEM.
Interestingly, qnr and aac(69) genes were detected in 76.9 % and 100 % of the 13 isolates, respectively ( Table 1) . The pAmpC gene designated bla ACT-1 -like was detected in only seven E. cloacae (53.8 %); three E. cloacae (E17, E22 and E23) isolates did not possess this gene. In the bla IMP-1 cassette, aac(69)-IIc was downstream of bla IMP-1 in nine E. cloacae, one K. oxytoca and one C. freundii (Table 1) . This result was similar to that of a previous study (Cagnacci et al., 2008) . One E. cloacae (E17) had the cassette arrangement bla IMP-1 -aac(69)-Ib, but the bla IMP-11 cassette array in one S. marcescens did not contain aac(69) genes. Therefore, while the presence of genes encoding aminoglycoside resistance has not yet been fully examined, our results suggest a close genetic association between quinolone resistance and aminoglycoside resistance in clinical isolates of IMP-1-type MBL-producing Enterobacteriaceae.
Plasmids were transferred successfully for three of 13 MBLproducing isolates (K4, S7 and E19; 
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Journal of Medical Microbiology 62 plasmids extracted from these donors and transconjugants (K4Tc, S7Tc and E19Tc) were deduced to be 65 kb (K4, E19, K4Tc and E19Tc) or 70 kb (S7 and S7Tc). Since K4Tc, S7Tc and E19Tc contained the same cassettes on each plasmid as K4, S7 and E19, respectively, our results also suggested that bla IMP -harbouring plasmids in donors were able to transfer to transconjugants, as described previously (Ode et al., 2009 ). On the other hand, since qnrB from E19 was present on plasmids other than those bearing bla IMP-1 , it was not transferred to E19Tc (Table 1, Fig. 1 ). Moreover, as the IPM and MEM MICs for transconjugants were lower than those for donors, factors other than MBL may increase carbapenem resistance. Therefore, to investigate further known carbapenem-resistance mechanisms, we assessed antimicrobial permeability, due to loss of OMPs, and overexpression of the efflux pump.
A lack of major porins (OmpK35 and OmpK36 in Klebsiella spp., OmpC and OmpF in Enterobacter spp., 41 and 38 kDa porins in C. freundii, and OmpF in S. marcescens) has been associated with carbapenem resistance (Doumith et al., 2009; Suh et al., 2010; Zhang et al., 2008) . Although the method in this study was subjective, OmpC or OmpF protein expression was reduced or deficient in all E. cloacae isolates (Table 1, Fig. 2a ), while OmpK36 was absent in one K. oxytoca isolate, in comparison to the IPM-susceptible strains (Table 1, Fig.  2b ). On the other hand, no reduction in OMP expression was observed in C. freundii or S. marcescens (data not shown). Moreover, the MICs of IPM and MEM did not differ by more than fourfold between isolates with and without EPI. Therefore, reduced expression or lack of OMPs may also contribute to decreased carbapenem susceptibility in E. cloacae and K. oxytoca isolates. However, the IPM and MEM MICs for isolate E17 with reduced OmpC expression were much higher than those of other strains. Although we could not clarify these results in the present study, they suggest the possibility that the highlevel resistance to IPM and MEM in E17 may be related to reduced expression or lack of porin-like proteins other than OmpC and OmpF, or to the presence of an efflux pump which is not inhibited by the EPI used in this study.
Although few isolates were examined, we have demonstrated that IMP-type MBL-producing Enterobacteriaceae with low-level IPM MICs frequently harboured various plasmid-mediated resistance genes. Furthermore, deficient OMP expression may further decrease carbapenem susceptibility in E. cloacae and K. oxytoca. This is the first study, to our knowledge, to demonstrate that both IMPtype MBL production and reduced expression or deficiency of OMPs may lead to acquisition of carbapenem resistance in such clinical isolates in Japan.
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